brt8k100413.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
 
___________________

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934


Date of Report: October 4, 2013
(Date of earliest event reported)


BIORESTORATIVE THERAPIES, INC.
(Exact Name of Registrant as Specified in Charter)

Nevada
000-54402
91-1835664
(State or Other Jurisdiction of Incorporation)
(Commission File No.)
(IRS Employer Identification Number)

555 Heritage Drive, Jupiter, Florida
    33458
(Address of Principal Executive Offices)
(Zip Code)


Registrant's telephone number, including area code: (561) 904-6070


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


____
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
____
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
____
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
____
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 

 
 
Item 5.07.
Submission of Matters to a Vote of Security Holders.

On October 4, 2013, the Company held its Annual Meeting of Shareholders (the “Annual Meeting”).  The following is a listing of the votes cast for or withheld, and the number of broker non-votes, with respect to each nominee for director and a listing of the votes cast for and against, as well as abstentions and broker-non votes, with respect to each other matter voted upon at the Annual Meeting.  The Company’s shareholders elected each of the nominees as a director, approved the Company’s executive compensation, recommended that future advisory votes on the Company’s executive compensation be held every three years and ratified the selection of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2013.

1.  
Election of Board of Directors:

   
Number of Shares
 
   
For
   
Withheld
   
Broker Non-Votes
 
Mark Weinreb
    6,915,725       80,137       1,766,923  
A. Jeffrey Radov
    6,935,725       60,137       1,766,923  
Joel San Antonio
    6,935,725       60,137       1,766,923  
                         
 2.           Approval of the Company’s executive compensation:

For
    6,863,712  
Against
    88,620  
Abstentions
    43,530  
Broker Non-Votes
    1,766,923  

3.           Frequency of future advisory votes on the Company’s executive compensation:

3 Years
    5,672,375  
2 Years
    549,378  
1 Year
    770,948  
Abstentions
    3,161  
         
4.           Ratification of the selection of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2013:

For
    8,731,668  
Against
    10,928  
Abstentions
    20,189  
         


 
 

 



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
  BIORESTORATIVE THERAPIES, INC.  
       
Dated: October 4, 2013
By:
/s/ Mark Weinreb  
    Mark Weinreb   
    Chief Executive Officer